Lantheus Holdings Inc. (LNTH) Raised to Buy at Zacks Investment Research
Lantheus Holdings Inc. (NASDAQ:LNTH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday. The firm presently has a $9.00 price target on the stock. Zacks Investment Research’s target price points to a potential upside of 12.22% from the stock’s current price.
According to Zacks, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. “
LNTH has been the subject of several other reports. Credit Suisse Group AG began coverage on Lantheus Holdings in a report on Friday, September 23rd. They issued a “neutral” rating and a $8.00 price objective for the company. Jefferies Group restated a “buy” rating on shares of Lantheus Holdings in a report on Friday, August 5th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Lantheus Holdings presently has an average rating of “Buy” and a consensus price target of $7.80.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/lantheus-holdings-inc-lnth-raised-to-buy-at-zacks-investment-research.html
Lantheus Holdings (NASDAQ:LNTH) opened at 8.02 on Wednesday. Lantheus Holdings has a one year low of $1.76 and a one year high of $10.10. The company has a market capitalization of $243.70 million, a price-to-earnings ratio of 9.05 and a beta of 0.47. The firm has a 50-day moving average of $8.45 and a 200 day moving average of $4.57.
Lantheus Holdings (NASDAQ:LNTH) last issued its earnings results on Thursday, August 4th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.18. The firm earned $78 million during the quarter, compared to analyst estimates of $72.66 million. Lantheus Holdings had a net margin of 9.00% and a negative return on equity of 11.75%. Equities research analysts predict that Lantheus Holdings will post $0.55 earnings per share for the current fiscal year.
A number of institutional investors have recently made changes to their positions in LNTH. Paloma Partners Management Co purchased a new position in shares of Lantheus Holdings during the second quarter worth approximately $179,000. Brigade Capital Management LP purchased a new position in shares of Lantheus Holdings during the second quarter worth approximately $5,219,000. Spark Investment Management LLC increased its position in shares of Lantheus Holdings by 33.2% in the second quarter. Spark Investment Management LLC now owns 141,300 shares of the company’s stock worth $518,000 after buying an additional 35,200 shares in the last quarter. TFS Capital LLC purchased a new position in shares of Lantheus Holdings during the second quarter worth approximately $156,000. Finally, Globeflex Capital L P purchased a new position in shares of Lantheus Holdings during the second quarter worth approximately $1,410,000. Institutional investors and hedge funds own 30.15% of the company’s stock.
Lantheus Holdings Company Profile
Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.